Day: February 3, 2021

Form 8.3 – [Creightons plc] – Opening Disclosure – (CGWL)

Written by Customer Service on February 3, 2021. Posted in Mergers And Acquisitions.

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study

Written by Customer Service on February 3, 2021. Posted in Public Companies.

SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced the initiation of a Phase 1 study of CRN04777, an oral, nonpeptide somatostatin receptor type 5 (SST5) agonist being developed as a treatment for congenital hyperinsulinism (HI). Congenital HI is a rare genetic disease associated with dysregulated insulin production in which excess insulin produces life-threatening hypoglycemia (low blood glucose) beginning at birth. The purpose of this study is to evaluate the safety and tolerability of CRN04777 in healthy adult volunteers. In addition, the study is designed to test the mechanism of action of CRN04777...

Brandywine Realty Trust announces Joint Venture with a Global Institutional Investor for its planned 570,000 GSF mixed-use tower at 3025 JFK Blvd within 14-acre, $3.5 billion Schuylkill Yards Neighborhood

Written by Customer Service on February 3, 2021. Posted in Public Companies.

PHILADELPHIA, Feb. 03, 2021 (GLOBE NEWSWIRE) — Brandywine Realty Trust (NYSE:BDN) today announced a partnership with a global institutional investor for its Schuylkill Yards West mixed-use tower at 3025 JFK Blvd. 3025 JFK is planned to be the first vertical development within the 14-acre, $3.5 billion Schuylkill Yards innovation neighborhood Brandywine is master developing in University City, Philadelphia, in partnership with Drexel University. The 570,000 SF project will cost approximately $287 million and will deliver 326 ultra-luxury rental residences, 200,000 SF of Life Science/Innovative Office space, 29,000 SF of indoor/outdoor amenity space and 9,000 SF of retail to the neighborhood. Commencement of construction is planned for March 2021, with an anticipated project completion date of October 2023.“As true believers in the...

Crown Crafts, Inc. to Announce Results for Fiscal 2021 Third Quarter

Written by Customer Service on February 3, 2021. Posted in Public Companies.

GONZALES, La., Feb. 03, 2021 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (the “Company”) (NASDAQ-CM: CRWS) today announced that it intends to release the results of its operations for the third quarter of fiscal year 2021 before the market opens on Wednesday, February 10, 2021. E. Randall Chestnut, Chairman and Chief Executive Officer, and Olivia W. Elliott, President, Chief Operating Officer and Chief Financial Officer, will host a teleconference at 1:00 p.m. Central Standard Time on that day to discuss the Company’s results and answer appropriate questions.Interested individuals may join the teleconference by dialing (844) 861-5504. Please ask to be joined into the Crown Crafts, Inc. call. The teleconference can also be accessed in listen-only mode by visiting the Company’s website at www.crowncrafts.com. The financial information to...

Coya Therapeutics Completes Merger with Nicoya Health Inc. and Announces $10 Million Series A Financing to Advance Pipeline of Regulatory T cell Therapeutics Optimized for Neurodegeneration and Autoimmune Diseases

Written by Customer Service on February 3, 2021. Posted in Mergers And Acquisitions.

-Seminal discoveries in regulatory T-cell (Treg) biology; Novel cryopreservation and manufacturing innovations based on the research of Stanley H. Appel, M.D., internationally renowned researcher and neurologist-HOUSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) — Coya Therapeutics, Inc., (Coya), a clinical-stage biotechnology company developing first-in-class approaches that utilize autologous regulatory T cells (Tregs) and allogeneic exosome therapeutics with a focus on neurodegenerative and autoimmune diseases, today announced that it has concurrently completed a merger with Nicoya Health, Inc. and raised $10 million in Series A financing from institutional and accredited investors. The merger and financing, which include conversion of outstanding debt, was led by Allele Capital Partners LLC. Howard Berman, Ph.D., has been appointed as...

Apollo Global Management, Inc. Reports Fourth Quarter and Full Year 2020 Results

Written by Customer Service on February 3, 2021. Posted in Public Companies.

NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”) today reported results for the fourth quarter and full year ended December 31, 2020.“The last decade has been a time of remarkable growth for Apollo and we believe our diversified platform has never been stronger. In the past year alone, we have added $124 billion in AUM or 38% – including $22 billion in the last quarter – to bring our total AUM to $455 billion,” said Leon Black, Founder, Chairman and Chief Executive Officer. “As part of our firm’s continued development, we are working on enhancements to our corporate governance that, subject to approvals, will be industry leading. In addition, we continue to evolve our leadership structure, including the recent naming of...

DFDS: Invitation to conference call for DFDS´ report for Q4 2020

Written by Customer Service on February 3, 2021. Posted in Public Companies.

February 03, 2021 06:56 ET | Source: DFDS A/S multilang-releaseInvestor news no. 05/2021 DFDS expects to publish the report for Q4 2020 on 10 February 2021 at around 08:00 AM CET. Torben Carlsen, CEO, and Karina Deacon, CFO, will present the report on a live conference call. The presentation in English will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part. Date: 10 February 2021 Time: 10:00 AM CET Telephone DK +45 35445577UK +44 33 33000804US +1 631 913 1422 List of international numbers: https://event.sharefile.com/d-s451667d1ca54c838 Access code: 81772821# If you wish to take part in the audio conference, please dial up at least five minutes before the conference begins. It will start on time, and participants will be asked to register name...

DFDS: Invitation til tele-konference om DFDS rapport for 4. kvt. 2020

Written by Customer Service on February 3, 2021. Posted in Public Companies.

February 03, 2021 06:56 ET | Source: DFDS A/S multilang-releaseInvestor news nr. 05/2021 DFDS’ kvartalsrapport for 4. kvt. 2020 forventes offentliggjort den 10. februar 2021 omkring kl. 08.00. Rapporten præsenteres på en tele-konference af Torben Carlsen, CEO og Karina Deacon, CFO. Efter præsentationen, der foregår på engelsk, vil der være mulighed for at stille spørgsmål. Investorer, analytikere og andre er velkommen til at deltage. Dato: 10. februar 2021 Tidspunkt: Kl. 10.00 Telefonnumre: DK +45 35445577 UK +44 33 33000804 US +1 631 913 1422 Liste over internationale telefonnumre: https://event.sharefile.com/d-s451667d1ca54c838 Adgangskode: 81772821# Deltagere...

Wabash National Corporation Announces Fourth Quarter and Full Year 2020 Results

Written by Customer Service on February 3, 2021. Posted in Public Companies.

Strengthening demand drives fourth quarter revenue of $404.1 millionFourth quarter operating income of $10.0 million, decremental margin of 12 percentFourth quarter earnings per diluted share of $0.10Backlog shows $500M sequential increase to $1.5 billion2021 EPS outlook initiated at $0.75 per diluted share; range of $0.70 to $0.80LAFAYETTE, Ind., Feb. 03, 2021 (GLOBE NEWSWIRE) — Wabash National Corporation (NYSE: WNC), the innovation leader of engineered solutions for the transportation, logistics and distribution industries, today reported results for the quarter and full year ended December 31, 2020.Net sales for the fourth quarter 2020 were $404.1 million while operating income was $10.0 million or 2.5% of net sales. For the full year 2020, total revenue totaled $1.5 billion while generating an operating loss of $(85.6) million...

Endeavour Silver Updates 2020 Mineral Reserve and Resource Estimates

Written by Customer Service on February 3, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (TSX: EDR, NYSE: EXK) reports updated Mineral Reserve and Resource Estimates for its three operating silver-gold mines in Mexico, Guanacevi in Durango state, Bolanitos in Guanajuato state and El Compas in Zacatecas state, and two key exploration and development projects, Terronera in Jalisco state and Parral in Chihuahua state.2020 Mineral Reserve and Resource Highlights (Compared to December 31, 2019)Silver Proven and Probable Mineral Reserves increased 11% to 48.6 million ounces (oz)Gold Proven and Probable Mineral Reserves decreased 1% to 472,000 ozSilver equivalent Proven and Probable Mineral Reserves of 86.3 million oz (80:1 silver:gold ratio)Silver Measured and Indicated Mineral Resources decreased 11% to 25.9 million ozGold Measured and Indicated...

Day: February 3, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals